1. Home
  2. PFN vs EMBC Comparison

PFN vs EMBC Comparison

Compare PFN & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFN
  • EMBC
  • Stock Information
  • Founded
  • PFN 2004
  • EMBC 1924
  • Country
  • PFN United States
  • EMBC United States
  • Employees
  • PFN N/A
  • EMBC N/A
  • Industry
  • PFN Finance/Investors Services
  • EMBC Medical/Dental Instruments
  • Sector
  • PFN Finance
  • EMBC Health Care
  • Exchange
  • PFN Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • PFN 692.7M
  • EMBC 782.5M
  • IPO Year
  • PFN N/A
  • EMBC N/A
  • Fundamental
  • Price
  • PFN $7.47
  • EMBC $14.01
  • Analyst Decision
  • PFN
  • EMBC Buy
  • Analyst Count
  • PFN 0
  • EMBC 2
  • Target Price
  • PFN N/A
  • EMBC $18.50
  • AVG Volume (30 Days)
  • PFN 331.7K
  • EMBC 318.1K
  • Earning Date
  • PFN 01-01-0001
  • EMBC 11-25-2025
  • Dividend Yield
  • PFN 11.66%
  • EMBC 4.28%
  • EPS Growth
  • PFN N/A
  • EMBC 18.26
  • EPS
  • PFN N/A
  • EMBC 1.42
  • Revenue
  • PFN N/A
  • EMBC $1,102,500,000.00
  • Revenue This Year
  • PFN N/A
  • EMBC N/A
  • Revenue Next Year
  • PFN N/A
  • EMBC N/A
  • P/E Ratio
  • PFN N/A
  • EMBC $9.87
  • Revenue Growth
  • PFN N/A
  • EMBC N/A
  • 52 Week Low
  • PFN $5.94
  • EMBC $9.20
  • 52 Week High
  • PFN $7.58
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • PFN 43.12
  • EMBC 49.90
  • Support Level
  • PFN $7.42
  • EMBC $13.75
  • Resistance Level
  • PFN $7.51
  • EMBC $14.43
  • Average True Range (ATR)
  • PFN 0.08
  • EMBC 0.43
  • MACD
  • PFN -0.01
  • EMBC 0.03
  • Stochastic Oscillator
  • PFN 50.00
  • EMBC 64.14

About PFN PIMCO Income Strategy Fund II

PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund. The company's primary investment objective is to seek high current income, consistent with the preservation of capital. The fund invests in a range of securities, such as corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, municipal bonds and notes, short-term instruments, sovereign Issues, preferred Securities and others.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: